Articles
Immunocellular: Pipeline Potential And Institutional Interest Fuel Rebound - Seeking Alpha - January 2012
Verastem IPO Validates Investor Interest In Cancer Stem Cell Approach - Seeking Alpha - January 2012
Current Trends In Cancer Therapeutic Development - Seeking Alpha - January 2012
Another Revival Could Be In Store For Immunocellular Therapeutics - Seeking Alpha - January 2012
Pharma Leaders Emerging In Immunotherapy Approach To Fighting Glioblastoma - Seeking Alpha - January 2012
Society For Neuro-Oncology Annual Meeting: Excitement Builds Around Immunotherapy - Seeking Alpha - December 2011
Improved Treatments for Brain Cancers Highlighted at Annual Society of Neuro-Oncology (SNO) Meeting - BioMedReports - December 2011
ImmunoCellular: Logistical Advantages Put The Company A Step Ahead In Cancer Treatment - Market Playground - November 2011
2 Top Biotech Plays With Safe Upside - Seeking Alpha - November 2011
ImmunoCellular: The Potential For A Cancer Vaccine - Seeking Alpha - November 2011
Stocks to Watch on Cancer Vaccines' Huge Financial Potential - InvestorPlace - November 2011
ImmunoCellular: at the "forefront" of targeting cancer stem cells, says Zacks - Proactive Investors - November 2011
3 Cancer Immunotherapy Biotechs With Catalysts For 2012 - Seeking Alpha - November 2011
ImmunoCellular Therapeutics' Cancer Stem Cell Drug Garnering Much Attention - Seeking Alpha - November 2011
ImmunoCellular's ICT-107 Touted As A Stand Out Therapeutic Vaccine - Seeking Alpha - November 2011
What A Nobel Prize Winner Knew And Savvy Biotech Investors Should - Seeking Alpha - October 2011
ImmunoCellular Therapeutics: The Biotechnology Moneyball - Seeking Alpha - October 2011
Big Healthcare Conference Offers Plenty Of New Plays To Pick From - Seeking Alpha - September 2011
Emerging Technologies In Brain Cancer Therapy - Seeking Alpha - September 2011
Key notes in Immunocellular's update - BioMed Reports - September 2011
IMUC, A Small But Interesting Player In Dendritic Cancer Vaccines - Seeking Alpha Article - August 2011
Navigating Cancer Vaccines High Risk-High Reward - Seeking Alpha Article - August 2011
A Few More Health Companies Beat Down with the Market - VFC Article - August 2011
Manish Singh- Cancer treatment revolution - M E Garza - August 2011
Dendreon's Price Destroyed-Could Immunocellular's Technology Offer an Assist - Seeking Alpha - August 2011
Healthcare-4 technical Set-ups with High Analyst Recommendations - Seeking Alpha - August 2011
Finding Some Help in the Healthcare Sector - Seeking Alpha - July 2011
ImmunoCellular Therapeutics' Upside Includes Buyout Potential - Seeking Alpha - July 2011
IMUC Ramps Up Value Proposition - Seeking Alpha Article - June 2011
ImmunoCellular Therapeutics: one of the most promising cancer immunotherapy plays - Proactive Investors - June 2011
IMUC Poised for Growth on Presentation of Phase I Data - Seeking Alpha Article - June 2011
Consider Investing in Companies Engaged in Immunotherapy - Seeking Alpha Article - June 2011
IMUCs' CEO on What's New in Cancer Therapy - Seeking Alpha Article - April 2011
ImmunoCellular Therapeutics A Biotech Value Play? - iStockAnalyst - March 2011
ImmunoCellular Therapeutics Meets AMEX Listing Requirements, Poised for Boost - Seeking Alpha Article - February 2011
Vaccine May Give Brain Cancer Patients Time KABC News - KABC 7 - February 2011
IMUC Resemblance to Dendreon - Seeking Alpha Article - February 2011
Has the Future Already Arrived for ImmunoCellular Therapeutics? - Seeking Alpha - December 2010
IMUC at Forefront - Zachs Article - November 2010
Eight Cancer Innovators to Watch Article - November 2010
IMUC Has All the Makings of Success Article - November 2010
IMUC's Vaccine Against Brain Cancer Article - October 2010
ImmunoCellular is Headed in the Right Direction - October 2010
CEO Explains economic significance of new vaccine manufacturing method - October 2010
Human Vaccines: News - Policy July 2010
Institutional Investor - Article - August 2010
Reuters - Article - Immunotherapy for tumors key topic at cancer meeting
Reuters - Article - Immunocellular brain cancer vaccine shows promise - June 2010
The OTC Investor - Could Be the Next Dendreon - July 2010
Vaccine News Daily - June 2010
VFC Stock House - July 2010
BioWorld Today - Provenge Nod Bodes Well but No Free Pass for Cancer Vaccines
Daily Finance - Inside Wall Street Why Hot Biotech Dendreon Could Get Even Hotter
mikehavRx.com - Immune-Based Treatments for Brain Cancer Post Impressive Early-Stage Results
Seeking Alpha - A New Strategy for ImmunoCellular Therapeutics
Seeking Alpha - ImmunoCellular's Promising Brain Cancer Vaccine
Seeking Alpha - ImmunoCellular Delivering on Key Milestones
Los Angeles Business Journal - Small Biotech Signs Pact with Roche Group
Reuters - ImmunoCellular in Research and License Option Deal with Roche
Seeking Alpha - ImmunoCellular Roche Pact Validates Pipeline Potential
Genetic Engineering & Biotechnology News – Dendreon’s $70M Investment in Production Capabilities Could Woo Firms without Similar Expertise
Genetic Engineering & Biotechnology News - A Stem of Hope for Cancer
BioMed Today - New Index of Cancer Diagnostic and Therapeutic Stocks
Pharmawire - ImmunoCellular Therapeutics looking for partner for monoclonal antibody vaccine, open to partnership for cancer stem cell vaccine - CEO
BioMed Today - ImmunoCellular Therapeutics: Targeting Cancer Stem Cellspacing=""
Reuters - Stem Cell Field Grows Despite Controversy Experts
Reuters - New Treatments Extend Brain Cancer Survival a Bit
Nature - Drug makers chase cancer stem cells
|
